Differential regulation of collagen secretion by kinin receptors in cardiac fibroblast and myofibroblast

Toxicology and Applied Pharmacology

Volumn 261, Issue 3, 2012, Pages 300-308

  Catalán, Mabel ^a   Smolic, Christian ^a   Contreras, Ariel ^a   Ayala, Pedro ^a   Olmedo, Ivonne ^a   Copaja, Miguel ^a   Boza, Pía ^a   Vivar, Raúl ^a   Avalos, Yennifer ^a   Lavandero, Sergio ^a,c   Velarde, Victoria ^b   Díaz Araya, Guillermo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Collagen; Fibroblast; Heart; Kinin receptor; Myofibroblast

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR; CALCIUM ION; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ICATIBANT; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KALLIDIN; N(G) NITROARGININE METHYL ESTER; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; HEART FIBROBLAST; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; IMMUNOLOCALIZATION; MYOFIBROBLAST; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; RADIOASSAY; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BINDING, COMPETITIVE; BLOTTING, WESTERN; CALCIUM; CALCIUM SIGNALING; COLLAGEN; CYCLOOXYGENASE INHIBITORS; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; KALLIDIN; KININS; MYOCARDIUM; MYOFIBROBLASTS; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84861229654     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.04.013     Document Type: Article

References (32)

1. Aránguiz-Urroz P., Soto D., Contreras A., Troncoso R., Chiong M., Montenegro J., Venegas D., Smolic C., Ayala P., Thomas W.G., Lavandero S., Díaz-Araya G. Differential participation of angiotensin II type 1 and 2 receptors in the regulation of cardiac cell death triggered by angiotensin II. Am. J. Hypertens. 2009, 22:569-576.
2. Balbay Y., Tikiz H., Baptiste R.J., Ayaz S., Sasmaz H., Korkmaz S. Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology 2001, 52:109-114.
3. Baum J., Duffy H.S. Fibroblasts and myofibroblasts: what are we talking about?. J. Cardiovasc. Pharmacol. 2011, 57:376-379.
4. Calixto J.B., Medeiros M., Fernandes E.S., Ferreira J., Cabrini D.A., Campos M.M. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 2004, 143:803-818.
5. Cheon H., Yu S.J., Yoo D.H., Chae I.J., Song G.G., Sohn J. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin. Exp. Immunol. 2002, 127:547-552.
6. Diaz-Araya G., Borg T.K., Lavandero S., Loftis M.J., Carver W. IGF-1 modulation of rat cardiac fibroblast behavior and gene expression is age-dependent. Cell Commun. Adhes. 2003, 10:155-165.
7. Enquist J., Skröde C., Whistler J.L., Leeb-Lundberg L.M. Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis. Mol. Pharmacol. 2007, 71:494-507.
8. Frangogiannis N.G. Chemokines in ischemia and reperfusion. Thromb. Haemost. 2007, 97:738-747.
9. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003, 200:500-503.
10. Gallagher A.M., Yu H., Printz M.P. Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 1998, 32:84-88.
11. Hayakawa K., Takemura G., Kanoh M., Li Y., Koda M., Kawase Y., Maruyama R., Okada H., Minatoguchi S., Fujiwara T., Fujiwara H. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 2003, 108:104-109.
12. Hinz B., Brune K. Cyclooxygenase-2, 10 years later. J. Pharmacol. Exp. Ther. 2002, 300:367-375.
13. Imai C., Okamura A., Peng J.F., Kitamura Y., Printz M.P. Interleukin-1beta enhanced action of kinins on extracellular matrix of spontaneous hypertensive rat cardiac fibroblasts. Clin. Exp. Hypertens. 2005, 27:59-69.
14. Kim N.N., Villegas S., Summerour S.R., Villarreal F.J. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J. Mol. Cell. Cardiol. 1999, 31:457-466.
15. LaPointe M.C., Mendez M., Leung A., Tao Z., Yang X.P. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1416-H1424.
16. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005, 57:27-77.
17. Luo J., Lang J.A., Miller M.W. Transforming growth factor β1 regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons. J. Neurochem. 1998, 71:526-534.
18. Mathis S.A., Criscimagna N.L., Leeb-Lundberg L.M. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells. Mol. Pharmacol. 1996, 50:128-139.
19. Maurer M., Barder M., Bas M., Bossi F., Cicardi M., Cugno M., Howarth P., Kaplan A., Kojda G., Leeb-Lundberg F., Lötvall J., Margerl M. New topics in bradykinin research. Allergy 2011, 66:1397-1406.
20. Moreau M.E., Garbacki N., Molinaro G., Brown N.J., Marceau F., Adam A. The kallikrein-kinin system: current and future pharmacological targets. J. Pharmacol. Sci. 2005, 99:6-38.
21. Phagoo S.B., Reddi K., Anderson K.D., Leeb-Lundberg L.M., Warburton D. Bradykinin B1 receptor up-regulation by interleukin-1beta and B1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts. J. Pharmacol. Exp. Ther. 2001, 298:77-85.
22. Pinsky D.J., Cai B., Yang X., Rodriguez C., Sciacca R.R., Cannon P.J. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J. Clin. Invest. 1995, 95:677-685.
23. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
24. Riad A., Walther T., Yang J., Altmann C., Escher F., Westermann D., Spillmann F., Schultheiss H.P., Tschöpe C. The cardiovascular influence of interleukin-1 beta on the expression of bradykinin B1 and B2 receptors. Int. Immunopharmacol. 2008, 8:222-230.
25. Riches K., Hettiarachchi N.T., Porter K.E., Peers C. Hypoxic remodelling of Ca2+ stores does not alter human cardiac myofibroblast invasion. Biochem. Biophys. Res. Commun. 2010, 403:468-472.
26. Rodriguez J.A., De la Cerda P., Collyer E., Decap V., Vio C.P., Velarde V. Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H30-H36.
27. Sun Y., Weber K.T. Infarct scar: a dynamic tissue. Cardiovasc. Res. 2000, 46:250-256.
28. Saito T., Rodger I.W., Hu F., Robinson R., Huyn T., Giaid A. Inhibition of COX pathway in experimental myocardial infarction. J. Mol. Cell. Cardiol. 2004, 37:71-77.
29. Simmons D.L., Botting R.M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56:387-437.
30. Van den Borne S.W.M., Diez J., Blankesteijn W.M., Verjans J., Hofstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 2010, 7:30-37.
31. Yu H., Gallagher A.M., Garfin P.M., Printz M.P. Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension 1997, 30:1047-1053.
32. Zidar N., Dolenc-Strazar Z., Jeruc J., Jerse M., Balazic J., Gartner U., Jermol U., Zupanc T., Stajer D. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the normal human heart and in myocardial infarction. Cardiovasc. Pathol. 2007, 16:300-304.